跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LYTGOBI futibatinib 4 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
LYTGOBI futibatinib 4 mg tablet blister pack
Approved
STANDARD
LYTGOBI futibatinib 4 mg tablet blister pack
Taiho Pharma Oceania Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
5c4a40014863e49f
Company
Taiho Pharma Oceania Pty Ltd
Type
Standard
Approval Details
Approval Id
5c4a40014863e49f
Product Name
LYTGOBI futibatinib 4 mg tablet blister pack
Artg Id
441350
Artg Name
LYTGOBI futibatinib 4 mg tablet blister pack
Sponsor
Taiho Pharma Oceania Pty Ltd
Company Detail Path
/organization/taiho-pharma-oceania-pty-ltd
Artg Date
2025-04-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
REP
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/892889cf3235d4020271200947b3ff5d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/b630ab36e6955ab4eba40bf5ccaa5987.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
5c4a40014863e49f
Type
Standard
Back to TGA Approvals